University Hospital, Basel, Switzerland: COVID-19 trials
The registry lists 12 COVID-19 studies with University Hospital, Basel, Switzerland as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)RecruitingNCT04625257
- Fever Tracking StudyCompletedNCT05475067
- Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA VaccineCompletedNCT05438472
- A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.CompletedNCT04760990
- Psychosocial Care During the COVID-19 Pandemic in Acute HospitalsCompletedNCT04753242
- SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital SettingCompletedNCT04519372
- Canakinumab in Patients With COVID-19 and Type 2 DiabetesCompletedNCT04510493Phase 3
- COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody ResponsesCompletedNCT04483908
- Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19CompletedNCT04472013
- Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19TerminatedNCT04414631Phase 2
- Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19CompletedNCT04389944Not applicable
- COVID-19 Survival - The COVIVA StudyCompletedNCT04366765